REDUCED INTENSITY CONDITIONING WITH FLUDARABINE, CYCLOPHOSPHAMIDE, AND HIGH DOSE RITUXAN FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR FOLLICULAR LYMPHOMA: A PHASE II MULTICENTER TRIAL FROM THE BLOOD AND MARROW TRANSPLANT NETWORK (BMT CTN)

Allogeneic hematopoietic cell transplantation (alloHCT) can induce long term remissions in chemosensitive relapsed follicular lymphoma (FL). The BMT CTN conducted a multicenter phase 2 trial to examine the efficacy of alloHCT using reduced intensity conditioning (RIC) with rituximab (RTX) in multipl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Laport, Ginna G, Wu, Juan, Logan, Brent, Bachanova, Veronika, Hosing, Chitra, Fenske, Timothy, Longo, Walter, Devine, Steven M, Nademanee, Auayporn, Gersten, Iris, Horowitz, Mary, Lazarus, Hillard M, Riches, Marcie L
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4949103/
https://ncbi.nlm.nih.gov/pubmed/27118571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.04.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados